Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator

BACKGROUND: Anti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock therapy in ventricular tachycardia (VT) termination with better quality of life. However, some ATPs may lead to VT acceleration or degeneration to ventricular fibrillation (VF), which will result in more ICD sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Sherien Samy, Azeez, Emmanuel Fares, Taha, Mohamed Ossama, El-Naggar, Wael Mohamed, El-Damaty, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236081/
https://www.ncbi.nlm.nih.gov/pubmed/37266828
http://dx.doi.org/10.1186/s43044-023-00369-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236081/
https://www.ncbi.nlm.nih.gov/pubmed/37266828
http://dx.doi.org/10.1186/s43044-023-00369-y

Ejemplares similares